Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
798.37
+4.17 (0.53%)
Aug 31, 2026, 1:15 PM EDT - Market open
Regeneron Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,456 | 3,118 | 2,488 | 2,730 | 3,106 | 2,886 |
Short-Term Investments | 5,539 | 5,487 | 6,524 | 8,115 | 4,636 | 2,809 |
Cash & Short-Term Investments | 7,995 | 8,605 | 9,013 | 10,845 | 7,742 | 5,695 |
Cash Growth | 7.03% | -4.52% | -16.90% | 40.07% | 35.96% | 58.76% |
Accounts Receivable | 6,280 | 5,356 | 5,844 | 5,299 | 5,023 | 5,059 |
Other Receivables | 285.6 | 384.9 | 367.8 | 368.5 | 305.6 | 977.5 |
Receivables | 6,565 | 5,741 | 6,212 | 5,667 | 5,329 | 6,037 |
Inventory | 3,084 | 3,201 | 3,087 | 2,581 | 2,402 | 1,951 |
Prepaid Expenses | 791.5 | 469.2 | 348.4 | 386.6 | 411.2 | 332.4 |
Restricted Cash | 10.2 | 5.6 | 0.8 | - | - | - |
Total Current Assets | 18,446 | 18,022 | 18,661 | 19,479 | 15,884 | 14,015 |
Property, Plant & Equipment | 5,459 | 5,366 | 4,817 | 4,224 | 3,834 | 3,482 |
Long-Term Investments | 10,630 | 10,595 | 9,060 | 5,471 | 6,640 | 6,878 |
Other Intangible Assets | 1,310 | 1,257 | 1,149 | 1,039 | 915.5 | 6.7 |
Long-Term Deferred Tax Assets | 4,381 | 4,077 | 3,314 | 2,575 | 1,724 | 876.9 |
Other Long-Term Assets | 1,505 | 1,241 | 758.8 | 291.8 | 216.9 | 176.1 |
Total Assets | 41,731 | 40,559 | 37,759 | 33,080 | 29,215 | 25,435 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,159 | 939 | 789.5 | 606.6 | 589.2 | 564 |
Accrued Expenses | 2,967 | 2,487 | 2,284 | 2,327 | 2,054 | 1,593 |
Current Portion of Leases | 720 | 37.8 | 30.3 | 19 | 12.4 | 719.7 |
Current Income Taxes Payable | - | 351.3 | 213.2 | 11.7 | - | 326.3 |
Current Unearned Revenue | 684.8 | 553 | 627.7 | 458.9 | 485.3 | 442 |
Other Current Liabilities | - | - | - | - | - | 287.4 |
Total Current Liabilities | 5,531 | 4,368 | 3,944 | 3,423 | 3,141 | 3,933 |
Long-Term Debt | 1,987 | 1,986 | 1,984 | 1,983 | 1,981 | 1,980 |
Long-Term Leases | - | 949 | 924.1 | 788.7 | 775.8 | - |
Long-Term Unearned Revenue | 220.4 | 208.7 | 185.7 | 126.7 | 69.8 | 73.3 |
Other Long-Term Liabilities | 2,282 | 1,790 | 1,367 | 785.4 | 582.2 | 680.2 |
Total Liabilities | 10,019 | 9,302 | 8,406 | 7,107 | 6,551 | 6,666 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 14,701 | 13,995 | 12,856 | 11,354 | 9,949 | 8,088 |
Retained Earnings | 37,621 | 35,797 | 31,673 | 27,260 | 23,307 | 18,968 |
Treasury Stock | -20,575 | -18,613 | -15,167 | -12,560 | -10,353 | -8,261 |
Comprehensive Income & Other | -35.8 | 77.5 | -7.9 | -80.9 | -238.8 | -26.2 |
Shareholders' Equity | 31,711 | 31,257 | 29,354 | 25,973 | 22,664 | 18,769 |
Total Liabilities & Equity | 41,731 | 40,559 | 37,759 | 33,080 | 29,215 | 25,435 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,707 | 2,973 | 2,939 | 2,791 | 2,770 | 2,700 |
Net Cash (Debt) | 15,116 | 15,893 | 14,974 | 13,451 | 11,565 | 9,833 |
Net Cash Growth | 1.98% | 6.14% | 11.32% | 16.31% | 17.61% | 144.18% |
Net Cash Per Share | 141.21 | 146.35 | 130.09 | 118.30 | 101.89 | 87.64 |
Filing Date Shares Outstanding | 99.85 | 102.62 | 106.82 | 107.46 | 106.73 | 106.44 |
Total Common Shares Outstanding | 100.32 | 102.6 | 107.1 | 107.12 | 107 | 106.57 |
Working Capital | 12,915 | 13,654 | 14,717 | 16,056 | 12,743 | 10,082 |
Book Value Per Share | 316.11 | 304.65 | 274.08 | 242.47 | 211.81 | 176.11 |
Tangible Book Value | 30,402 | 30,000 | 28,205 | 24,935 | 21,749 | 18,762 |
Tangible Book Value Per Share | 303.05 | 292.39 | 263.35 | 232.78 | 203.26 | 176.05 |
Land | - | 278.8 | 288.2 | 283.1 | 264.5 | 248 |
Buildings | - | 3,106 | 2,573 | 2,423 | 2,270 | 2,089 |
Machinery | - | 2,285 | 2,149 | 1,940 | 1,803 | 1,662 |
Construction In Progress | - | 1,890 | 1,722 | 1,345 | 980.5 | 767.7 |
Leasehold Improvements | - | 174.4 | 154.5 | 133.9 | 114.3 | 113.9 |